Activation Of Central Alpha 7 Nicotinic Acetylcholine Receptor Reverses Suppressed Immune Function Of T Lymphocytes And Protects Against Sepsis Lethality

Chao Ren,Xiu-Hua Li,Shi-Bin Wang,Li-Xue Wang,Ning Dong,Yao Wu,Yong-Ming Yao
DOI: https://doi.org/10.7150/ijbs.24576
2018-01-01
International Journal of Biological Sciences
Abstract:Sepsis remains the leading cause of high mortality and huge financial burden in intensive care units (ICU), but with scarce effective treatments due to refractory multiple organ dysfunction and persistent immunosuppression. Treatments that aim at modulating immune function and attenuating multiple organ injury will certainly benefit septic cases. Alpha 7 nicotinic acetylcholine receptor (alpha 7nAchR) has been reported with potent immunomodulatory properties in various diseases as the essential mediator of the cholinergic anti-inflammatory pathway (CAP). Few studies have demonstrated the potential effect of central alpha 7nAchR on the progression and prognosis of septic response, while its expression was first discovered on neurons and most abundant in the central nervous system. In the present study, it was found severe damage of multiple organs under the operation of cecal ligation and puncture (CLP) in rats, including heart, liver, kidneys, and lungs, as evidenced by abnormal histomorphology and notable elevation of injury markers. Concurrently, the function of spleen CD4(+)T cells was disrupted under septic challenge, accompanied by polarization of helper T cell (Th)2, which exhibited outward signs of immunosuppression. Intracerebroventricular injection of PNU282987, a selective agonist of alpha 7nAchR, significantly alleviated multiple organ injury, reversed immunosuppressive state, and improved the outcome of septic rats, while they were exacerbated by treatment with methyllycaconitine, a selective antagonist of alpha 7nAchR. This study provides the first evidence that activation of central alpha 7nAchR is beneficial for attenuating multiple organ dysfunction as well as abnormal immune response, and improving the prognosis of rats when exposed with sepsis.
What problem does this paper attempt to address?